Clinical Study
Life beyond 5 Years after TAVI: Patients’ Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation
Table 2
Procedural characteristics.
| | Variable | n (%) |
| | Valve type | | | Edward bioprosthesis | 60 (58.8) | | CoreValve | 41 (40.2) | | JenaValve | 1 (1.0) |
| | Access, n (%) | | | Transfemoral | 68 (65.0) | | Transapical | 35 (35.0) | | Prosthesis after dilatation, n (%) | 13 (12.7) | | Valve-in-valve, n (%) | 5 (5.0) |
| | Prosthesis diameter, n (%) | | | 23 mm | 22 (21.6) | | 25 mm | 1 (1.0) | | 26 mm | 51 (50.0) | | 29 mm | 26 (25.5) | | 31 mm | 2 (2.0) |
| | Anaesthesia | | | Local | 64 (62.1) | | General | 39 (37.9) |
|
|
Data are expected as absolute values (n) and percentages (%).
|
